.png "back to home page")
• Inovio는 보도 자료에서 규제 기관의 질문에 답하기 위해 노력하고 있으며 10 월에 FDA에 응답할 계획이며 FDA는 30 일 이내에 임상 시험을 진행할 수 있는지에 대한 결정을 내릴 것이라고 말했습니다.
Inovio's shares tumble 33% as COVID-19 vaccine trial is put on hold [www.marketwatch.com]
Inovio tanks 39% after pausing coronavirus vaccine trial, trading halted [markets.businessinsider.com]
Inovio Plunges; FDA Puts Partial Hold On Covid Vaccine Trial [www.thestreet.com]
Access to this page has been denied. [www.investors.com]
• Inovio는이 시험이 임상 시험에 사용될 전달 장치와 FDA의 질문에 적절하게 답변 할 때까지 "일부 임상 보류"상태라고 말했습니다.
Login to comment
Open Wiki
- Feel free to edit it. -
9/29 '20
answered
$opti Another vaccine went down...
— Phoenix (@lvald13) September 28, 2020
Inovio's shares halted, COVID-19 trial put on hold: https://t.co/U7J7a2uv64
$INO (-31.8% pre) Inovio's shares tumble 33% as COVID-19 vaccine trial is put on hold - MWhttps://t.co/NYvoNDyUX5
— Open Outcrier (@OpenOutcrier) September 28, 2020
Inovio has delayed the phase 2/3 trial of its DNA-based coronavirus vaccine after the FDA raised questions https://t.co/j1jJpxuUYD
— RR Seattle (@RRalstonAgile) September 28, 2020
Another setback for $INO's Covid-19 vaccine: A Phase 2/3 trial set to begin this month won't, because @US_FDA has more questions and put a clinical hold on the study, @JaredSHopkins reports https://t.co/iTBbQtmQvR. Inovio shares down ~28%.
— Jonathan Rockoff (@jonathanrockoff) September 28, 2020
Login to comment